Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Through education and awareness, patients can feel more empowered to take an active role in their treatment, leading to better health outcomes and improved quality of life
Retatrutide is an investigational triple-agonist peptide designed to activate: GLP-1 (Glucagon-Like Peptide-1) receptors GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors Glucagon receptors By targeting all three pathways, retatrutide addresses appetite regulation, insulin resistance, energy expenditure, and fat metabolism together rather than focusing on appetite suppression alone
If pain requires daily medication or stomach symptoms persist, medical advice is needed
Basal insulin intensification: mealtime bolus insulin or GLP-1RA
Others prefer morning injections so the nausea window aligns with their least active hours
US$ 22.80
US$ 21.42
US$ 20.50
US$ 23.94
US$ 23.84
US$ 21.70
US$ 24.53
US$ 21.02
US$ 23.06
